Prio Wealth Limited Partnership’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.44M | Buy |
42,748
+38
| +0.1% | +$7.09K | 0.25% | 75 |
|
|
2024
Q2 | $7.33M | Sell |
42,710
-16,676
| -28% | -$2.76M | 0.22% | 79 |
|
|
2024
Q1 | $10.8M | Buy |
59,386
+15,268
| +35% | +$2.63M | 0.31% | 73 |
|
|
2023
Q4 | $6.84M | Buy |
44,118
+183
| +0.4% | +$26.7K | 0.23% | 77 |
|
|
2023
Q3 | $6.55M | Sell |
43,935
-1,412
| -3% | -$207K | 0.25% | 74 |
|
|
2023
Q2 | $6.11M | Sell |
45,347
-2,987
| -6% | -$438K | 0.22% | 76 |
|
|
2023
Q1 | $7.7M | Sell |
48,334
-38,815
| -45% | -$5.93M | 0.3% | 72 |
|
|
2022
Q4 | $14.1M | Sell |
87,149
-344
| -0.4% | -$52.7K | 0.56% | 53 |
|
|
2022
Q3 | $11.7M | Sell |
87,493
-7,714
| -8% | -$1.11M | 0.5% | 56 |
|
|
2022
Q2 | $14.6M | Sell |
95,207
-3,988
| -4% | -$609K | 0.58% | 50 |
|
|
2022
Q1 | $16.1M | Sell |
99,195
-1,565
| -2% | -$227K | 0.53% | 54 |
|
|
2021
Q4 | $13.6M | Sell |
100,760
-320
| -0.3% | -$37.8K | 0.42% | 60 |
|
|
2021
Q3 | $10.9M | Sell |
101,080
-59
| -0.1% | -$6.74K | 0.37% | 63 |
|
|
2021
Q2 | $11.4M | Sell |
101,139
-4,848
| -5% | -$546K | 0.38% | 62 |
|
|
2021
Q1 | $11.5M | Sell |
105,987
-3,023
| -3% | -$323K | 0.41% | 58 |
|
|
2020
Q4 | $11.7M | Sell |
109,010
-1,249
| -1% | -$120K | 0.44% | 55 |
|
|
2020
Q3 | $9.66M | Sell |
110,259
-1,382
| -1% | -$130K | 0.4% | 61 |
|
|
2020
Q2 | $11M | Sell |
111,641
-7,609
| -6% | -$670K | 0.51% | 53 |
|
|
2020
Q1 | $9.09M | Sell |
119,250
-10,708
| -8% | -$912K | 0.5% | 55 |
|
|
2019
Q4 | $11.5M | Sell |
129,958
-13,300
| -9% | -$1.1M | 0.49% | 56 |
|
|
2019
Q3 | $10.8M | Sell |
143,258
-4,162
| -3% | -$285K | 0.5% | 57 |
|
|
2019
Q2 | $10.7M | Sell |
147,420
-8,850
| -6% | -$696K | 0.49% | 55 |
|
|
2019
Q1 | $12.6M | Sell |
156,270
-3,822
| -2% | -$313K | 0.59% | 50 |
|
|
2018
Q4 | $14.8M | Sell |
160,092
-575
| -0.4% | -$50.6K | 0.79% | 40 |
|
|
2018
Q3 | $15.2M | Buy |
160,667
+4,188
| +3% | +$397K | 0.69% | 43 |
|
|
2018
Q2 | $14.5M | Sell |
156,479
-959
| -0.6% | -$93.7K | 0.72% | 44 |
|
|
2018
Q1 | $14.9M | Sell |
157,438
-11,190
| -7% | -$1.23M | 0.74% | 42 |
|
|
2017
Q4 | $16.3M | Sell |
168,628
-950
| -0.6% | -$89.5K | 0.76% | 42 |
|
|
2017
Q3 | $15.1M | Sell |
169,578
-459
| -0.3% | -$34.9K | 0.74% | 45 |
|
|
2017
Q2 | $12.3M | Sell |
170,037
-3,056
| -2% | -$205K | 0.61% | 48 |
|
|
2017
Q1 | $11.3M | Sell |
173,093
-1,659
| -0.9% | -$104K | 0.58% | 50 |
|
|
2016
Q4 | $10.9M | Sell |
174,752
-5,193
| -3% | -$317K | 0.58% | 51 |
|
|
2016
Q3 | $11.3M | Sell |
179,945
-461
| -0.3% | -$29.8K | 0.6% | 52 |
|
|
2016
Q2 | $11.2M | Sell |
180,406
-181
| -0.1% | -$11K | 0.61% | 51 |
|
|
2016
Q1 | $10.3M | Sell |
180,587
-1,776
| -1% | -$99K | 0.56% | 55 |
|
|
2015
Q4 | $10.8M | Sell |
182,363
-232
| -0.1% | -$13.4K | 0.59% | 51 |
|
|
2015
Q3 | $9.93M | Sell |
182,595
-1,850
| -1% | -$120K | 0.56% | 55 |
|
|
2015
Q2 | $12.4M | Sell |
184,445
-5,006
| -3% | -$327K | 0.64% | 52 |
|
|
2015
Q1 | $11.1M | Sell |
189,451
-383
| -0.2% | -$23.1K | 0.55% | 58 |
|
|
2014
Q4 | $12.4M | Sell |
189,834
-4,079
| -2% | -$257K | 0.62% | 55 |
|
|
2014
Q3 | $11.2M | Buy |
193,913
+4,680
| +2% | +$260K | 0.58% | 54 |
|
|
2014
Q2 | $10.7M | Sell |
189,233
-13,603
| -7% | -$714K | 0.54% | 59 |
|
|
2014
Q1 | $10.4M | Sell |
202,836
-700
| -0.3% | -$35.4K | 0.53% | 61 |
|
|
2013
Q4 | $10.7M | Sell |
203,536
-1,190
| -0.6% | -$58.5K | 0.54% | 56 |
|
|
2013
Q3 | $9.16M | Buy |
204,726
+4,860
| +2% | +$215K | 0.52% | 60 |
|
|
2013
Q2 | $8.26M | Buy |
+199,866
| New | +$8.74M | 0.5% | 65 |
|
Other funds holding ABBV
Prio Wealth Limited Partnership's ABBV Position: Q3 2024 in Review
Prio Wealth Limited Partnership increased its AbbVie (ABBV) stake by 0.09% in Q3 2024, buying an estimated $7.09K and bringing the position to 42,748 shares worth $8.44M. The position accounts for 0.25% of the portfolio, ranked #75.
Prio Wealth Limited Partnership first reported a position in ABBV in Q2 2013 and has held it in 46 quarters since. The position peaked at $16.3M in Q4 2017. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.
- Prio Wealth Limited Partnership held 42,748 shares of AbbVie worth $8.44M as of Q3 2024.
- Prio Wealth Limited Partnership bought 38 AbbVie shares in Q3 2024, an estimated $7.09K.
- AbbVie made up 0.25% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #75 holding.
- Prio Wealth Limited Partnership first reported a position in AbbVie in Q2 2013 and has held it in 46 quarters since.
- Prio Wealth Limited Partnership's AbbVie position peaked at $16.3M in Q4 2017.
- 3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.
Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.